Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

Concentration-controlled treatment of lupus nephritis with mycophenolate mofetil.

Daleboudt GM, Reinders ME, den Hartigh J, Huizinga TW, Rabelink AJ, de Fijter JW, Berger SP.

Lupus. 2013 Feb;22(2):171-9. doi: 10.1177/0961203312469261. Epub 2012 Dec 20.

PMID:
23257398
[PubMed - indexed for MEDLINE]
2.

Maintenance therapy with mycophenolate mofetil for children with severe lupus nephritis after low-dose intravenous cyclophosphamide regimen.

Fujinaga S, Ohtomo Y, Hara S, Umino D, Someya T, Shimizu T, Kaneko K.

Pediatr Nephrol. 2008 Oct;23(10):1877-82. doi: 10.1007/s00467-008-0800-7. Epub 2008 Apr 15.

PMID:
18414900
[PubMed - indexed for MEDLINE]
3.

Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategies.

Zahr N, Amoura Z, Debord J, Hulot JS, Saint-Marcoux F, Marquet P, Piette JC, Lechat P.

Clin Pharmacokinet. 2008;47(4):277-84.

PMID:
18336056
[PubMed - indexed for MEDLINE]
4.

Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.

Tett SE, Saint-Marcoux F, Staatz CE, Brunet M, Vinks AA, Miura M, Marquet P, Kuypers DR, van Gelder T, Cattaneo D.

Transplant Rev (Orlando). 2011 Apr;25(2):47-57. doi: 10.1016/j.trre.2010.06.001. Epub 2010 Dec 28.

PMID:
21190834
[PubMed - indexed for MEDLINE]
5.

Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients.

Kuypers DR, de Jonge H, Naesens M, de Loor H, Halewijck E, Dekens M, Vanrenterghem Y.

Clin Ther. 2008 Apr;30(4):673-83.

PMID:
18498916
[PubMed - indexed for MEDLINE]
7.

Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.

Contreras G, Tozman E, Nahar N, Metz D.

Lupus. 2005;14 Suppl 1:s33-8.

PMID:
15803929
[PubMed - indexed for MEDLINE]
8.

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

van Gelder T, Hilbrands LB, Vanrenterghem Y, Weimar W, de Fijter JW, Squifflet JP, Hené RJ, Verpooten GA, Navarro MT, Hale MD, Nicholls AJ.

Transplantation. 1999 Jul 27;68(2):261-6.

PMID:
10440399
[PubMed - indexed for MEDLINE]
9.

Therapeutic drug monitoring of mycophenolate mofetil for the treatment of severely active lupus nephritis.

Kittanamongkolchai W, Rukrung C, Supasiri T, Lertjirachai I, Somparn P, Chariyavilaskul P, Avihingsanon Y.

Lupus. 2013 Jun;22(7):727-32. doi: 10.1177/0961203313486949. Epub 2013 May 7.

PMID:
23651860
[PubMed - indexed for MEDLINE]
10.

Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil.

Zahr N, Arnaud L, Marquet P, Haroche J, Costedoat-Chalumeau N, Hulot JS, Funck-Brentano C, Piette JC, Amoura Z.

Arthritis Rheum. 2010 Jul;62(7):2047-54. doi: 10.1002/art.27495.

PMID:
20506558
[PubMed - indexed for MEDLINE]
Free Article
11.

Mycophenolate mofetil in patients with systemic lupus erythematosus: a prospective pharmacokinetic study.

Roland M, Barbet C, Paintaud G, Magdelaine-Beuzelin C, Diot E, Halimi JM, Lebranchu Y, Nivet H, Büchler M.

Lupus. 2009 Apr;18(5):441-7. doi: 10.1177/0961203308098631.

PMID:
19318398
[PubMed - indexed for MEDLINE]
12.

Population pharmacokinetics of mycophenolate mofetil in Thai lupus nephritis patients.

Punyawudho B, Lertdumrongluk P, Somparn P, Kittanamongkolchai W, Traitanon O, Avihingsanon Y, Vadcharavivad S.

Int J Clin Pharmacol Ther. 2012 Apr;50(4):272-80.

PMID:
22456298
[PubMed - indexed for MEDLINE]
13.

Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.

Musuamba FT, Rousseau A, Bosmans JL, Senessael JJ, Cumps J, Marquet P, Wallemacq P, Verbeeck RK.

Clin Pharmacokinet. 2009;48(11):745-58. doi: 10.2165/11318060-000000000-00000.

PMID:
19817503
[PubMed - indexed for MEDLINE]
14.

The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients.

Jirasiritham S, Sumethkul V, Mavichak V, Na-Bangchang K.

Transplant Proc. 2004 Sep;36(7):2076-8.

PMID:
15518751
[PubMed - indexed for MEDLINE]
15.

The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis.

Baskin E, Ozen S, Cakar N, Bayrakci US, Demirkaya E, Bakkaloglu A.

Pediatr Nephrol. 2010 Jan;25(1):111-7. doi: 10.1007/s00467-009-1291-x. Epub 2009 Sep 1.

PMID:
19727839
[PubMed - indexed for MEDLINE]
16.

Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study.

Laskari K, Mavragani CP, Tzioufas AG, Moutsopoulos HM.

Arthritis Res Ther. 2010;12(6):R208. doi: 10.1186/ar3184. Epub 2010 Nov 9.

PMID:
21059275
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis with poor kidney function: a subgroup analysis of the Aspreva Lupus Management Study.

Walsh M, Solomons N, Lisk L, Jayne DR.

Am J Kidney Dis. 2013 May;61(5):710-5. doi: 10.1053/j.ajkd.2012.11.042. Epub 2013 Feb 1.

PMID:
23375819
[PubMed - indexed for MEDLINE]
18.

Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation.

Filler G, Foster J, Berard R, Mai I, Lepage N.

Transplant Proc. 2004 Jun;36(5):1327-31.

PMID:
15251324
[PubMed - indexed for MEDLINE]
19.

Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.

Sahin GM, Sahin S, Kiziltas S, Masatlioglu S, Oguz F, Ergin H.

Ren Fail. 2008;30(9):865-9. doi: 10.1080/08860220802353843.

PMID:
18925525
[PubMed - indexed for MEDLINE]
20.

Defining algorithms for efficient therapeutic drug monitoring of mycophenolate mofetil in heart transplant recipients.

Kaczmarek I, Bigdeli AK, Vogeser M, Mueller T, Beiras-Fernandez A, Kaczmarek P, Schmoeckel M, Meiser B, Reichart B, Ueberfuhr P.

Ther Drug Monit. 2008 Aug;30(4):419-27. doi: 10.1097/FTD.0b013e31817d7064.

PMID:
18641552
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk